PRIMOBOLIC - Methenolone Enanthate 100mg/200mg

Category:- Hormones | Type:- Injection

Each ml contains: Methenolone Enanthate 100 mg

PHARMACOLOGICALPROPERTIES:
The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has moderate anabolic effects and weak androgenic effects.

INDICATIONS:
Methenolone has the ability to increase strength without significantly increasing muscular bulk, which is useful for athletes who aren't bodybuilders. It promotes increased muscular endurance and recuperation. Because it helps to increase one's metabolic rate, it is an excellent fat burner.

CONTRA-INDICATIONS:
Not intended for use in children.
Known or suspected prostatic carcinoma and mammary carcinoma in the male.
Not intended for use in female patients other than those with disseminated breast cancer.
Contraindicated in nephrosis or the nephrotic phase of nephritis, cardiac and renal failure, hypercalcaemia, oedema, jaundice, liver disease with impaired bilirubin excretion, testicular and hepatic carcinoma.

DOSAGE AND DIRECTIONS FOR USE:
Primobolic should be administered by deep intramuscular injection. Adult dose: 50-100 mg every 3 weeks.

SIDE-EFFECTS AND SPECIALPRECAUTIONS:
Virilisation which appears in sensitive women as hoarseness, acne, hirsutism, and increased libido; in prepubertal boys as an increased frequency of erections and phallic enlargement, and in girls as an increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocal change which may end in a long-lasting, sometimes irreversible deepening of the voice.

OTHER ADVERSE REACTIONS MAYINCLUDE:
Oligospermia and decreased ejaculatory volume; Suppression of ovarian activity, atrophy of the breasts and endometrial tissue. Amenorrhoea and inhibition of spermatogenesis. Water and salt retention. Premature epiphyseal closure. If signs of virilisation develop, treatment should be discontinued. Increase in nitrogen retention and skeletal weight; Oedema; Increased vascularity of the skin; Increased growth of the bone; Elderly males may become over-stimulated.

PATIENTS WITH THE FOLLOWING CONDITIONS SHOULD BE MONITORED:
Latent or overt cardiac failure, renal dysfunction, hypertension, epilepsy or migraine (or a history of these conditions), since anabolic steroids may induce salt and fluid retention; diabetes, since anabolic steroids may improve the glucose tolerance and decrease the need for insulin or other antidiabetic drugs; incomplete statural growth, since anabolic steroids in high dosages may accelerate epiphyseal closure; skeletal metastases, since anabolic steroids may induce hypercalcaemia and hypercalciuria in these patients, liver dysfunction.

INTERACTIONS:
Liver-enzyme-inducing agents may reduce the effects of Primobolic by enhancing its metabolism in the liver.